Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
 
 
Email
csiywp@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2010 TO 2020]
Subject:  Life Sciences & Biomedicine
File Format:  Adobe PDF
Date Issued:  2016

Results 1-3 of 3 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
110-Oct-2016A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activationOng, Pei-Shi ; Wang, Lingzhi ; Chia, Deborah Miao-Hui; Seah, Jolyn Yu-Xin; Kong, Li-Ren ; Thuya, Win-Lwin ; Chinnathambi, Arunachalam; Lau, Jie-Ying Amelia ; Wong, Andrea Li-Ann ; Yong, Wei-Peng ; Yang, Daiwen ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Goh, Boon-Cher 
23-May-2016Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinomaHuang, Baohua ; DENG SHUO ; LOO SER YUE ; ARPITA DATTA ; YAP YAN LIN ; Yan, Benedict; OOI CHIA HUEY ; DINH THUY DUONG ; ZHUO JINGLI ; LALCHHANDAMI TOCHHAWNG ; SUMA GOPINADHAN ; Jegadeesan, Tamilarasi; TAN BOON OOI,PATRICK ; SALTO-TELLEZ,MANUEL ; YONG WEI PENG ; SOONG CHUAN TECK,RICHIE ; YEOH KHAY GUAN ; GOH YAW CHONG ; PETER EDWARD LOBIE ; YANG HE ; ALAN PREM KUMAR ; Maciver, Sutherland K; SO BOK YAN,JIMMY ; Yap Suen Mei,Celestial Therese 
31-Jul-2016High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547Lau, Wen Min ; Teng, Eileen ; Huang, Kie Kyon ; Tan, Jin Wei ; Teh, Ming ; Yong, Wei Peng ; Sommer, Anette; Schatz, Christoph A; Tan, Patrick ; Chan, Shing Leng ; So, Jimmy